DUSP1 and breast carcinoma: Given the very low (3.23–5.2%) methylation frequency in PBL DNA, DUSP1 methylation has potential as a biomarker in non-invasive breast cancer diagnosis if we can detect DUSP1 methylation from circulating cell-free DNA in plasma that is released by breast tumour cells.